Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

This study aimed to identify predictive factors associated with prognostic benefits of gefitinib. A total of 221 Japanese patients who received gefitinib (250 mg day(−1)) were examined retrospectively and potential predictive factors analysed. Overall response rate (ORR) was 24.4% and median surviva...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Satouchi, M, Negoro, S, Funada, Y, Urata, Y, Shimada, T, Yoshimura, S, Kotani, Y, Sakuma, T, Watanabe, H, Adachi, S, Takada, Y, Yatabe, Y, Mitsudomi, T
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2007
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360147/
https://ncbi.nlm.nih.gov/pubmed/17387341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603710
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars